These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16619524)

  • 21. Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer.
    Gofrit ON; Zorn KC; Taxy JB; Lin S; Zagaja GP; Steinberg GD; Shalhav AL
    J Urol; 2007 Nov; 178(5):1925-8. PubMed ID: 17868725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
    Raaijmakers R; de Vries SH; Blijenberg BG; Wildhagen MF; Postma R; Bangma CH; Darte C; Schröder FH
    Eur Urol; 2007 Nov; 52(5):1358-64. PubMed ID: 17499425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
    Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
    Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
    Khatami A; Hugosson J; Wang W; Damber JE
    Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saturation biopsy improves preoperative Gleason scoring of prostate cancer.
    Kahl P; Wolf S; Adam A; Heukamp LC; Ellinger J; Vorreuther R; Solleder G; Buettner R
    Pathol Res Pract; 2009; 205(4):259-64. PubMed ID: 19106019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy.
    Cheng L; Davidson DD; Lin H; Koch MO
    Cancer; 2007 Nov; 110(9):1967-72. PubMed ID: 17823907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7.
    Mian C; Lodde M; Comploj E; Palermo S; Lusuardi L; Marziani F; Chiocchetti A; Spada A; Mian M; Pycha A
    Prostate; 2006 Jun; 66(9):966-70. PubMed ID: 16541423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.
    van Dekken H; Tilanus HW; Hop WC; Dinjens WN; Wink JC; Vissers KJ; van Marion R
    Cancer Genet Cytogenet; 2009 Feb; 189(1):37-42. PubMed ID: 19167610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients.
    Song SY; Kim SR; Ahn G; Choi HY
    Prostate Cancer Prostatic Dis; 2003; 6(2):143-7. PubMed ID: 12806373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
    Miyamoto H; Hernandez DJ; Epstein JI
    Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization.
    Wolter H; Gottfried HW; Mattfeldt T
    BJU Int; 2002 Feb; 89(3):310-6. PubMed ID: 11856117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
    Roobol MJ; Grenabo A; Schröder FH; Hugosson J
    J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.
    Qiu YQ; Leuschner I; Braun PM
    Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of prostatic carcinoma with artificial neural networks using comparative genomic hybridization and quantitative stereological data.
    Mattfeldt T; Gottfried HW; Wolter H; Schmidt V; Kestler HA; Mayer J
    Pathol Res Pract; 2003; 199(12):773-84. PubMed ID: 14989489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis.
    Roemeling S; Kranse R; Vis AN; Gosselaar C; van der Kwast TH; Schröder FH
    Cancer; 2006 Dec; 107(12):2779-85. PubMed ID: 17109445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
    Vijayakumar S; Hall DC; Reveles XT; Troyer DA; Thompson IM; Garcia D; Xiang R; Leach RJ; Johnson-Pais TL; Naylor SL
    Cancer Res; 2006 Apr; 66(8):4055-64. PubMed ID: 16618725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.
    Pinthus JH; Witkos M; Fleshner NE; Sweet J; Evans A; Jewett MA; Krahn M; Alibhai S; Trachtenberg J
    J Urol; 2006 Sep; 176(3):979-84; discussion 984. PubMed ID: 16890675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.